In US Hispanics, cancer remains leading cause of death
the ONA take:
Cancer remains the leading cause of death among Hispanics in the United States, according to an American Cancer Society report published in CA: A Cancer Journal for Clinicians.
In “Cancer Statistics for Hispanics/Latinos,” a comprehensive report published every 3 years, Rebecca Siegel, MPH, director of surveillance information for the American Cancer Society, and fellow researchers found that 125,900 new cancer cases and 37,800 cancer deaths are expected among Hispanics/Latinos living in the United States in 2015.
Cancer incidence rates are 20% lower and cancer death rates are 30% lower in Hispanics than in non-Hispanic whites due to a lower incidence rate of the four most common cancers (prostate, breast, lung, and colon).
However, Hispanics are at a higher risk for cancers associated with infectious agents, such as cancers of the stomach, liver, and cervix.
Lung cancer was found to be the leading cause of cancer death among Hispanic men, accounting for about 17%, or 1 in 6 deaths. According to 2015 estimates, liver cancer is expected to surpass colorectal cancer as the second leading cause of death in this population.
In Hispanic women, the leading cause of cancer death is breast cancer at a 16% death rate, followed by lung and colorectal cancers. Lung cancer death rates were found to be 70% lower in Hispanic women compared to non-Hispanic white women due to a lower prevalence of smoking.
Cancer death rates are declining at a rate of 2.4% per year in men, as well as 0.5% per year in women.
“The growth in the population of US residents of Hispanic origin is now driven primarily by births, not immigration, which will probably change the future cancer risk profile of this group,” said Siegel.
Cancer remains the leading cause of death among Hispanics in the U.S.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Patients and Caregivers Worry About Cost of Cancer Care
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|